DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Kerala Ayurveda Ltd (KERALAYUR) share price today?

Kerala Ayurveda Ltd (KERALAYUR) is trading at ₹167.2 on the BSE, up 0.60% on the day. Source: DocStoX.

What is the PE ratio of Kerala Ayurveda Ltd?

Kerala Ayurveda Ltd has a price-to-earnings (PE) ratio of 134.3 in the Healthcare sector.

What is the market capitalisation of Kerala Ayurveda Ltd?

Kerala Ayurveda Ltd has a market capitalisation of approximately ₹214 crore.

Kerala Ayurveda Ltd

KERALAYUR·BSE·Healthcare

₹167.20▲ +1.00 (+0.60%)

Healthcare · Pharmaceuticals & Biotechnology

Carries meaningful debt — watch the balance sheet

Day₹164.00

₹169.90

52W₹150

₹6104%

Open

₹165.10

High

₹169.90

Low

₹164.00

Prev Close

₹166.20

Volume

4.7K

VWAP

₹166.10

Snapshot

Key fundamentals

Market Cap

₹214 Cr

P/E Ratio

134.29Expensive

P/B Ratio

18.90

EPS

₹1.25

Book Value

₹8.79

ROE

N/A

ROCE

-9.00%Weak

Dividend Yield

0.00%

Debt / Equity

7.82High

Face Value

₹10.00

52W High

₹610.00

52W Low

₹150.00

Sector

Healthcare

Industry

Pharmaceuticals & Biotechnology

Fairly Valued

None moatExtreme uncertainty

Fair value unavailable

/100

Business quality — Watch the fundamentals

Growth 50Profitability 0Efficiency 0Valuation 0

Plain English

Our view

Carries meaningful debt — watch the balance sheet
High leverage — debt exceeds 1.5× equity

Risks

High leverage — debt exceeds 1.5× equity
Expensive — trades at 134× earnings

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

134.3Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

—

ROCE

-9.0%Weak

Above 18% means capital is working hard

Debt/Eq

7.82High

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹214 Cr

P/B

18.90

EPS

₹1.25

Div Yield

—

What changed

Recent changes

Promoters+2.47% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 134.3×

Growth

Steady

+12% rev CAGR

Profitability

N/A

No ROE

Financial health

High debt

D/E 7.82

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹7.75L Cr

Trades60

VWAP₹166.10

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+12.1%

+16.2%

10Y

+11.1%

Profit

—

10Y

—

EPS

—

10Y

—

Profile

Pros

Debtor days have improved from 51.1 to 38.4 days.

Watch-outs

Cons

Stock is trading at 19.4 times its book value
Company has low interest coverage ratio.
Promoter holding is low: 35.6%
Company has a low return on equity of -85.2% over last 3 years.
Promoter holding has decreased over last 3 years: -25.9%

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 2.47 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

36%

Promoter

Promoters

35.6%+2.47

Public

42.2%-2.26

FII / FPI

0.2%-0.05

DII

0.0%0.00

Others

22.0%

Total shareholders

10,184+232 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter35.61%

FII0.17%

DII0.04%

Public42.16%

Others22.02%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]